tiprankstipranks
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
US Market

Acro Biomedical Co (ACBM) Financial Statements

11 Followers

Acro Biomedical Co Financial Overview

Acro Biomedical Co's market cap is currently $1.56M. The company's EPS TTM is $-0.0024; its P/E ratio is -10.83; Acro Biomedical Co is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 658.50K$ 1.20M
Gross Profit$ 0.00$ 0.00$ 0.00$ 140.50K$ 259.50K
Operating Income$ -154.02K$ -37.96K$ -8.80M$ -15.87M$ -7.69M
EBITDA$ -154.02K$ -37.96K$ 0.00$ -15.87M$ 0.00
Net Income$ -101.15K$ -42.30K$ -8.81M$ -15.87M$ -7.70M
Balance Sheet
Cash & Short-Term Investments$ 4.10K$ 476.00$ 376.00$ 5.85K$ 95.25K
Total Assets$ 14.10K$ 31.97K$ 58.46K$ 687.49K$ 761.08K
Total Debt$ 325.51K$ 26.90K$ 52.23K$ 25.72K$ 50.43K
Net Debt$ 321.41K$ 26.42K$ 51.86K$ 19.87K$ -44.82K
Total Liabilities$ 401.06K$ 326.95K$ 315.47K$ 201.12K$ 117.37K
Stockholders' Equity$ -386.96K$ -294.97K$ -257.01K$ 486.37K$ 643.71K
Cash Flow
Free Cash Flow$ -196.30K$ -36.69K$ -15.45K$ -147.48K$ 299.33K
Operating Cash Flow$ -196.30K$ -36.69K$ -15.45K$ -147.48K$ 299.33K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 199.92K$ 36.79K$ 9.97K$ 58.09K$ -222.21K
Currency in USD

Acro Biomedical Co Earnings and Revenue History

Acro Biomedical Co Debt to Assets

Acro Biomedical Co Cash Flow

Acro Biomedical Co Forecast EPS vs Actual EPS